First Look Analyst Calls Briefing for Thursday, November 17, 2022
Here are the early analysts' research calls for Thursday.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Allete (ALE) upgraded to Neutral from Underweight at JP Morgan; tgt $65
> Ardelyx (ARDX) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $8
> Banco Bradesco (BBD) upgraded to Overweight from Neutral at JP Morgan
Downgrades:
> Aveanna (AVAH) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $2
> IQVIA (IQV) downgraded to Neutral from Buy at Citigroup; tgt lowered to $245
> Kinnate BioPharma (KNTE) downgraded to Hold from Buy at Stifel; tgt lowered to $11
> Quest Diagnostics (DGX) downgraded to Sell from Neutral at Citigroup; tgt lowered to $125
> REE Automotive (REE) downgraded to Neutral from Buy at BTIG Research
> Science Applications (SAIC) downgraded to Hold from Buy at Jefferies; tgt $110
> Two Harbors Investment (TWO) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $16
Others:
> Dragonfly Energy (DFLI) initiated with a Buy at Stifel; tgt $12
> Edgewell Personal Care (EPC) initiated with a Buy at Canaccord Genuity; tgt $48
> e.l.f. Beauty (ELF) initiated with a Buy at Canaccord Genuity; tgt $63
> Energizer (ENR) initiated with a Hold at Canaccord Genuity; tgt $34
> Energy Recovery (ERII) initiated with a Buy at B. Riley Securities; tgt $28
> Estee Lauder (EL) initiated with a Hold at Canaccord Genuity; tgt $228
> Grove Collaborative Holdings (GROV) initiated with a Buy at Canaccord Genuity; tgt $2
> Helen of Troy (HELE) initiated with a Buy at Canaccord Genuity; tgt $120
> KemPharm (KMPH) initiated with an Overweight at Cantor Fitzgerald; tgt $20
> Middleby (MIDD) initiated with a Buy at Canaccord Genuity; tgt $171
> Olaplex (OLPX) initiated with a Buy at Canaccord Genuity; tgt $8
> Prestige Consumer (PBH) initiated with a Buy at Canaccord Genuity; tgt $71
> Solo Brands (DTC) initiated with a Buy at Canaccord Genuity; tgt $7
> Theratechnologies (THTX) initiated with an Overweight at Cantor Fitzgerald; tgt $9
> Thorne HealthTech (THRN) initiated with a Buy at Canaccord Genuity; tgt $5.50
> Traeger (COOK) initiated with a Buy at Canaccord Genuity; tgt $6
> Vaxcyte (PCVX) initiated with a Buy at BTIG Research; tgt $69
> YETI Holdings (YETI) initiated with a Buy at Canaccord Genuity; tgt $58
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.